Clinical trial
The Efficacy and Safety of Degludec Insulin Use for Glycemic Control in Critically Ill Patients: A Prospective Interventional Study (Protocol)
NCT06056167 is registered in ClinicalTrials.gov with King Faisal Specialist Hospital & Research Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of Degludec Insulin Use for Glycemic Control in Critically Ill Patients: A Prospective Interventional Study (Protocol)
- Lead sponsor
- King Faisal Specialist Hospital & Research Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 17, 2023
- Completion date
- May 30, 2024
- Enrollment
- 155 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.